The human immunodeficiency virus Tat proteins specifically associate with TAK in vivo and require the carboxyl- terminal domain of RNA polymerase II for function

Journal of Virology

Volumn 70, Issue 7, 1996, Pages 4576-4584

  Yang, Xinzhen ^a   Herrmann, Christine H ^a   Rice, Andrew P ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN SERINE THREONINE KINASE; RNA POLYMERASE II; TAK PROTEIN; TRANSACTIVATOR PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; GENE MAPPING; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; TRANSCRIPTION REGULATION; VIRUS TRANSCRIPTION;

ANIMALS; BINDING SITES; CELL LINE, TRANSFORMED; CERCOPITHECUS AETHIOPS; GENE PRODUCTS, TAT; HELA CELLS; HIV-1; HIV-2; HUMANS; PHOSPHORYLATION; PROTEIN-SERINE-THREONINE KINASES; RNA POLYMERASE II;

EID: 0029943536     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.70.7.4576-4584.1996     Document Type: Article

References (52)

1. Adams, M., L. Sharmeen, J. Kimplon, J. M. Romeo, J. V. Garcia, B. M. Peterlin, M. Groudine, and M. Emerman. 1994. Cellular latency in human immunodeficiency virus-infected individuals with high CD4 levels can he detected by the presence of promoter-proximal transcripts. Proc. Natl. Acad. Sci. USA 91:3862-3866.
2. Aguilar-Cordova, E., J. Chinen, L. Donehower, D. E. Lewis, and J. W. Belmont. 1994. A sensitive reporter cell line for HIV-1 tat activity, HIV-1 inhibitors, and T cell activation effects. AIDS Res. Hum. Retroviruses 10: 295-301.
3. Aiyar, A., and J. Leis. 1993. Modification of the megaprimer method of PCR mutagenesis: improved amplification of the final product. BioTechniques 14:366-369.
4. Braddock, M., A. M. Thorburn, A. J. Kingsman, and S. M. Kingsman. 1991. Blocking of Tat-dependent HIV-1 RNA modification by an inhibitor of RNA polymerase II processivity. Nature (London) 350:439-441.
5. Brake, D. A., J. Goudsmit, W. J. Krone, P. Schammel, N. Appleby, R. H. Meloen, and C. Debouck. 1990. Characterization of murine monoclonal antibodies to the tat protein from human immunodeficiency virus type 1. J. Virol. 64:962-965.
6. Carroll, R., L. Martarano, and D. Derse. 1991. Identification of lentivirus tat functional domains through generation of equine infectious anemia virus/human immunodeficiency virus type 1 tat gene chimeras. J. Virol. 65:3460-3467.
7. Carroll, R., B. M. Peterlin, and D. Derse. 1992. Inhibition of human immunodeficiency virus type 1 Tat activity by coexpression of heterologous trans activators. J. Virol. 66:2000-2007.
8. Corden, J. L. 1993. RNA polymerase II transcription cycles. Curr. Opin. Genet. Dev. 3:213-218.
9. Cullen, B. R. 1986. Trans-activation of human immunodeficiency virus occurs via a bimodal mechanism. Cell 46:973-982.
10. Cullen, B. R. 1995. Regulation of HIV gene expression. AIDS 9(Suppl. A):S19-S32.
11. Dahmus, M. E. 1994. The role of multisite phosphorylation in the regulation of RNA polymerase II activity. Prog. Nucleic Acid Res. Mol. Biol. 48:143-179.
12. Dayton, A. I., J. G. Sodroski, C. A. Rosen, W. C. Goh, and W. A. Haseltine. 1986. The trans-activator gene of the human T cell lymphotropic virus type III is required for replication. Cell 44:941-947.
13. Echetebu, C. O., H. Rhim, C. H. Herrmann, and A. P. Rice. 1994. Construction and characterization of a potent HIV-2 Tat transdominant mutant protein. J. Acquired Immune Defic. Syndr. 7:655-664.
14. Emerman, M., M. Guyader, L. Monlagnier, D. Baltimore, and M. A. Muesing. 1987. The specificity of the human immunodeficiency virus type 2 transactivator is different from that of human immunodeficiency virus type 1. EMBO J. 6:3755-3760.
15. Feinberg, M. B., D. Baltimore, and A. D. Frankel. 1991. The role of Tat in the human immunodeficiency virus life cycle indicates a primary effect on transcriptional elongation. Proc. Natl. Acad. Sci. USA 88:4045-4049.
16. Fenrick, R., M. H. Malim, J. Hauber, S. Y. Le, J. Maizel, and B. R. Cullen. 1989. Functional analysis of the Tat trans activator of human immunodeficiency virus type 2. J. Virol. 63:5006-5012.
17. Fisher, A. G., M. B. Feinberg, S. F. Josephs, M. E. Harper, L. M. Marselle, G. Reyes, M. A. Gonda, A. Aldovini, C. Debouk, R. C. Gallo, et al. 1986. The trans-activator gene of HTLV-III is essential for virus replication. Nature (London) 320:367-371.
18. Frankel, A. D., D. S. Bredl, and C. O. Pabo. 1988. Tat protein from human immunodeficiency virus forms a metal-linked dimer. Science 240:70-73.
19. Gait, M. J., and J. Karn. 1993. RNA recognition by the human immunodeficiency virus Tat and Rev proteins. Trends Biochem. Sci. 18:255-259.
20. Gerber, H. P., M. Hagmann, K. Seipel, O. Georgiev, M. A. West, Y. Litingtung, W. Schaffner, and J. L. Corden. 1995. RNA polymerase II C-terminal domain required for enhancer-driven transcription. Nature (London) 374: 660-662.
21. Gibbs, J. B., and A. Oliff. 1994. Pharmaceutical research in molecular oncology. Cell 79:193-198.
22. Harlow, E., and D. Lane. 1988. Antibodies: a laboratory manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
23. Hauber, J., M. Bouvier, M. H. Malim, and B. R. Cullen. 1988. Phosphorylation of the rev gene product of human immunodeficiency virus type 1. J. Virol. 62:4801-4804.
24. Herrmann, C. H., M. O. Gold, and A. P. Rice. 1996. Viral transactivators specifically target distinct cellular protein kinases that phosphorylate the RNA polymerase II C-terminal domain. Nucleic Acids Res. 24:501-509.
25. Herrmann, C. H., and A. P. Rice. 1993. Specific interaction of the human immunodeficiency virus Tat proteins with a cellular protein kinase. Virology 197:601-608.
26. Herrmann, C. H., and A. P. Rice. 1995. Lentivirus Tat proteins specifically associate with a cellular protein kinase, TAK, that hyperphosphorylates the carhoxyl-terminal domain of the large suhunit of RNA polymerase II: candidate for a Tat cofactor. J. Virol. 69:1612-1620.
27. Jones, K. A., and B. M. Peterlin. 1994. Control of RNA initiation and elongation at the HIV-1 promoter. Annu. Rev. Biochem. 63:717-743.
28. Kao, S. Y., A. F. Calman, P. A. Luciw, and B. M. Peterlin. 1987. Antitermination of transcription within the long terminal repeat of HIV-1 by tat gene product. Nature (London) 338:489-493.
29. Kuppuswamy, M., T. Subramanian, A. Srinivasan, and G. Chinnadurai. 1989. Multiple functional domains of Tat, the trans-activator of HIV-1, denned by mutational analysis. Nucleic Acids Res. 17:3551-3561.
30. Laspia, M. F., A. P. Rice, and M. B. Mathews. 1989. HIV-1 Tat protein increases transcriptional initiation and stabilizes elongation. Cell 59:283-292.
31. MacGregor, G. R., and C. T. Caskey. 1989. Construction of plasmids that express E. coli beta-galactosidase in mammalian cells. Nucleic Acids Res. 17:2365.
32. Madore, S. J., and B. R. Cullen. 1993. Genetic analysis of the cofactor requirement for human immunodeficiency virus type 1 Tat function. J. Virol. 67:3703-3711.
33. Marciniak, R. A., B. J. Calnan, A. D. Frankel, and P. A. Sharp. 1990. HIV-1 Tat protein trans-activates transcription in vitro. Cell 63:791-802.
34. Marciniak, R. A., and P. A. Sharp. 1991. HIV-1 Tat protein promotes formation of more-processive elongation complexes. EMBO J. 10:4189-4196.
35. Marshall, N. F., and D. H. Price. 1992. Control of formation of two distinct classes of RNA polymerase II elongation complexes. Mol. Cell. Biol. 12: 2078-2090.
36. Marshall, N. F., and D. H. Price. 1995. Purification of P-TEFh, a transcription factor required for the transition into productive elongation. J. Biol. Chem. 270:12335-12338.
37. Meyers, G., B. Korber, S. Wain-Hobson, R. F. Smith, and G. N. Pavlakis. 1994. Human retroviruses and AIDS. Los Alamos National Laboratory, Los Alamos, N.Mex.
38. Peterson, S. R., A. Dvir, C. W. Anderson, and W. S. Dynan. 1992. DNA binding provides a signal for phosphorylation of the RNA polymerase II heptapeptide repeats. Genes Dev. 6:426-438.
39. Rhim, H., F. Chan, C. O. Echetebu, and A. P. Rice. 1993. Rapid purification of monomer HIV-2 Tat protein expressed in Escherichia coli. Protein Expression Purif. 4:24-31.
40. Rhim, H., C. O. Echetebu, C. H. Herrmann, and A. P. Rice. 1994. Wild-type and mutant HIV-1 and HIV-2 Tat proteins expressed in Escherichia coli as fusions with glutathione S-transferase. J. Acquired Immune Defic. Syndr. 7:1116-1121.
41. Rhim, H., and A. P. Rice. 1994. Exon 2 of HIV-2 Tat contributes to transactivation of the HIV-2 LTR by increasing binding affinity to HIV-2 TAR RNA. Nucleic Acids Res. 22:4405-4413.
42. Rhim, H., and A. P. Rice. 1994. Functional significance of the dinucleotide bulge in stem-loop 1 and stem-loop 2 of HIV-2 TAR RNA. Virology 202: 202-211.
43. Rhim, H., and A. P. Rice. Unpublished data.
44. Rice, A. P., and F. Carlotti. 1990. Mutational analysis of the conserved cysteine-rich region of the human immunodeficiency virus type 1 Tat protein. J. Virol. 64:1864-1868.
45. Rice, A. P., and F. Carlotti. 1990. Structural analysis of wild-type and mutant human immunodeficiency virus type 1 Tat proteins. J. Virol. 64:6018-6026.
46. Rosen, C. A., J. G. Sodroski, and W. A. Haseltine. 1985. The location of cis-acting regulatory sequences in the human T cell lymphotropic virus type III (HTLV-III/LAV) long terminal repeat. Cell 41:813-823.
47. Sadaie, M. R., J. Rappaport, T. Benter, S. F. Josephs, R. Willis, and F. Wong-Staal. 1988. Missense mutations in an infectious human immunodeficiency viral genome: functional mapping of tat and identification of the rev splice acceptor. Proc. Natl. Acad. Sci. USA 85:9224-9228.
48. Sif, S., and T. D. Gilmore. 1994. Interaction of v-rel oncoprotein with cellular transcription factor Spl. J. Virol. 68:7131-7138.
49. Southgate, C. D., and M. R. Green. 1991. The HIV-1 Tat protein activates transcription from an upstream DNA-binding site: implications for Tat function. Genes Dev. 5:2496-2507.
50. Watson, M. E., and M. Moore. 1993. A quantitative assay for trans-activation by HIV-1 Tat, using liposome-mediated DNA uptake and a parallel ELISA system. AIDS Res. Hum. Retroviruses 9:861-867.
51. Yang, X., and A. P. Rice. Unpublished data.
52. Zawel, L., and D. Reinberg. 1993. Initiation of transcription by RNA polymerase II: a multi-step process. Prog. Nucleic Acid Res. Mol. Biol. 44:67-108.